Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms

NCT04427384 is registered in ClinicalTrials.gov with GT Medical Technologies, Inc. as lead sponsor.

NCT NCT04427384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04427384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms
Lead sponsor
GT Medical Technologies, Inc.
Phase
Observational
Overall status
Recruiting
Start date
September 11, 2020
Completion date
December 31, 2028
Enrollment
600 (estimated)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, brain tumor - metastatic, brain tumor, adult meningioma, brain tumor, adult: glioblastoma, brain tumor, primary, brain tumor, recurrent